Researchers uncover new role of mutant proteins in some of the deadliest cancers
Researchers at the National Institutes of Health (NIH) and their collaborators have discovered a new way in which RAS genes, ...
Synthetic Biology Market to Hit USD 31.52 Billion by 2029 with 20.6% CAGR | MarketsandMarkets
The global synthetic biology market is anticipated to reach USD 31.52 billion in 2029 from USD 12.33 billion in 2024, with a ...
Topical Drug Delivery Market is expected to generate a revenue of USD 177.97 Billion by 2031, Globally, at 6.3% CAGR: Verified Market Research
Verified Market Research®, a leading provider of business intelligence and market analysis is thrilled to announce the release of its comprehensive and authoritative report on the Topical Drug ...
Morningstar2h
Novavax to Move Forward With Covid-19, Influenza Vaccine After FDA Lifts Clinical Hold
Novavax can move forward with a trial for its combined Covid-19 and influenza vaccine after regulators lifted a clinical hold. The Gaithersburg, Md., vaccine developer said Monday that the U.S. Food ...
Yahoo Finance2h
U.S. FDA Removes Clinical Hold on Novavax's COVID-19-Influenza Combination and Stand-alone Influenza Phase 3 Trial
has removed the clinical hold on Novavax's Investigational New Drug (IND) application for its COVID-19-Influenza Combination ...
Unicycive: FDA to Review Lead Drug Candidate for Hyperphosphatemia
Unicycive, which is seeking an FDA green light for oxylanthanum carbonate to treat hyperphosphatemia in patients with chronic kidney disease who are on dialysis, Monday said the agency set a target ...
Brainstorm Cell Therapeutics And Pluri Partner To Support Nurown® Phase 3B Trial Manufacturing
Memorandum of Understanding has been signed NEW YORK, Nov. 11, 2024 /PRNewswire/ -- BrainStorm Cell Therapeutics Inc ...
The Bakersfield Californian5h
Unicycive Therapeutics Announces U.S. FDA Acceptance of the New Drug Application (NDA) for ...
FDA sets PDUFA Action Date of June 28, 2025 ...
Dizal seeks FDA approval for NSCLC treatment sunvozertinib
Dizal has submitted sunvozertinib’s new drug application (NDA) to the US Food and Drug Administration (FDA) aiming to secure approval for treating locally advanced or metastatic non-small cell lung ...
Corbus Pharmaceuticals' Sell-Off: Speculative Entry Price In Oncology And Obesity Therapies
Corbus Pharmaceuticals still shows promise, with CRB-701 and CRB-601 advancing in clinical trials. Read why CRBP stock is ...
Alembic Pharmaceuticals gets USFDA nod for hypertension treatment capsules
Alembic Pharmaceuticals Ltd on Monday said it has received final approval from the US health regulator for its generic ...
Alembic Pharma gets US FDA nod for Diltiazem Hydrochloride ER capsules
Alembic Pharmaceuticals said that it has received final approval from the US Food & Drug Administration (USFDA) for its abbreviated new drug application (ANDA) for Diltiazem Hydrochloride ...